RE
institution

Rejuveron

Switzerlandrejuveron.com

Rejuveron is an investor based in Switzerland, investing in Healthcare & Life Sciences, Pharmaceutical Development and Biotechnology, 1 tracked investment.

1
Investments Tracked

About Rejuveron

Rejuveron is an investor based in Switzerland. Brouky tracks 1 investment associated with the firm.

Rejuveron invests across Healthcare & Life Sciences, Pharmaceutical Development, Biotechnology and Biotech. Coverage extends to 8 sectors in total. Investments are concentrated at Series B.

Rejuveron invests in healthcare and life sciences companies. They focus on series-b stage companies.

Investment Focus

Stage Focus
series-b
Sectors
Healthcare & Life Sciencespharmaceutical-developmentbiotechnologybiotechaiaging-techr-dmachine-learning

Investment Thesis

Rejuveron invests in healthcare and life sciences companies. They focus on series-b stage companies.

Team

Christian AngermayerCo-founder and Chair of the Board

Christian Angermayer is an entrepreneur and investor as well as the founder of Apeiron Investment Group, his family office and asset management business. Apeiron focuses on Life Sciences, FinTech/InsurTech/PropTech & Crypto and DeepTech (e.…

Shannon KlingerIndependent Board Member

Shannon Thyme Klinger is the Chief Legal Officer of Moderna, Inc. She has over 25 years of global leadership experience in the pharmaceutical industry across a wide range of functional areas, including legal, compliance, IP, licensing, merg…

Etienne BinantChief Executive Officer

Etienne’s career spans over 25 years of entrepreneurship and financing in the Healthcare (Biotech and Medtech) and IT spaces. Etienne has successfully led more than successful 100 fundraisings in those spaces, all across Europe and the USA,…

Aaron WeaverChief Strategy Officer

Aaron is a seasoned investor and operator of life science companies. He has provided expert counsel on numerous types of capital market issuances, emerging markets debt, covered bonds, high yield and restructurings. He has lead investor rel…

Lisa BalsigerOperations Manager

With over a decade of executive assistance experience, Lisa has transitioned into the role of Operations Manager, bringing her expertise in optimizing efficiency and streamlining processes. Fluent in English, German, and French, she excels…

Matt KaeberleinScientific Advisory Board

CEO of Optispan and Affiliate Professor of Oral Health at the University of Washington. Founding Director of the University of Washington Healthy Aging and Longevity Research Institute. Research focused on understanding the biological mecha…

Prof. Brian KennedyScientific Advisory Board

Former President and CEO of the Buck Institute for Research on Aging. Director of the Centre for Healthy Ageing and Distinguished Professor in Biochemistry and Physiology at the Yong Loo Lin School of Medicine at National University Singapo…

Guido KoremerScientific Advisory Board

Professor at the University of Paris Cité. Renowned for discovering that mitochondrial membrane permeabilization is a key step in programmed cell death, contributing to immunogenic antineoplastic treatments.

Explore Rejuveron's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in Switzerland

Other Investors in Healthcare & Life Sciences / Pharmaceutical Development